Abstract
One of the aims of assisted reproduction technologies (ART) is the recruitment of multiple follicles ensuring the recovery of good-quality oocytes upon controlled ovarian hyperstimulation (COH). In recent years, the number of patients in whom few oocytes are obtained in response to COH is increasing. This phenomenon mainly is probably related to the postponement of childbearing to the fourth decade of life. In this group of patients, multifollicular response to COH remains a challenge, but the optimisation of laboratory strategies may help to maximise their chances of pregnancy. Ovarian response to COH varies widely among patients and is strictly dependent on the size of the ovarian pool of resting follicles, the so-called ovarian reserve [1]. In women with a reduced ovarian reserve, a poor ovarian response results in a low number of retrieved oocytes despite the high dose of gonadotropins administered. Hence, although tests for predicting ovarian reserve are available [2], the parameter that best categorises a woman as a ‘poor responder’ remains the ovarian response itself. The incidence of poor ovarian response (POR) is estimated between 9 and 24 % [3–5]. This value increases with age [3, 5] reaching about 50 % in women over 40 years [6]. Women who respond poorly to COH have pregnancy rates that vary from 7.6 to 17.5 %, while in normal responders, they vary from 25.9 to 36.7 %. Female age plays a distinct role in predicting poor response to COH; in fact, older poor responders have lower pregnancy rates (ranging between 1.5 and 12.7 %) compared with younger poor responders (ranging between 13.0 and 35 %) [2]. A second predicting factor of pregnancy outcome in poor responders is the degree of poor response. A lower number of retrieved oocytes results in fewer embryos to transfer and a lower chance of pregnancy, in addition to the expected negative effect of poor ovarian function on oocyte quality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lashen H, Ledger W, Lopez-Bernal A, Barlow D (1999) Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod 14:964–969
Oudendijk JF, Yarde F, Eijkemans MJC, Broekmans FJM, Broer SL (2012) The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update 18:1–11
Ben-Rafael Z, Bider D, Dan U, Zolti M, Levran D, Mashiach S (1991) Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG. J In Vitro Fert Embryo Transf 8:33–36
Surrey ES, Schoolcraft WB (2000) Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73:667–676
Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J (2003) Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9:61–76
Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L (2011) ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 26:1616–1624
Oehninger S, Gosden RG (2002) Should ICSI be the treatment of choice for all cases of in-vitro conception? No, not in light of the scientific data. Hum Reprod 17:2237–2242
Van der Westerlaken L, Helmerhorst F, Dieben S, Naaktgeboren N (2005) Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization. Fertil Steril 83:612–617
Moreno C, Ruiz A, Simón C, Pellicer A, Remohí J (1998) Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod 13:2126–2129
Gozlan I, Dor A, Farber B, Meirow D, Feinstein S, Levron J (2007) Comparing intracytoplasmic sperm injection and in vitro fertilization in patients with single oocyte retrieval. Fertil Steril 87:515–518
Borini A, Gambardella A, Bonu MA, Dal Prato L, Sciajno R, Bianchi L et al (2009) Comparison of IVF and ICSI when only few oocytes are available for insemination. Reprod Biomed Online 19:270–275
Artini PG, Obino MER, Carletti E, Pinelli S, Ruggiero M, Di Emidio G et al (2013) Conventional IVF as a laboratory strategy to rescue fertility potential in severe poor responder patients: the impact of reproductive aging. Gynecol Endocrinol 29:997–1001
Palermo G, Joris H, Devroey P, Van Steirteghem AC (1992) Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340:17–18
Payne D, Flaherty SP, Jeffrey R, Warnes GM, Matthews CD (1994) Successful treatment of severe male factor infertility in 100 consecutive cycles using intracytoplasmic sperm injection. Hum Reprod 9:2051–2057
Calderón G, Belil I, Aran B, Veiga A, Gil Y, Boada M et al (1995) Intracytoplasmic sperm injection versus conventional in-vitro fertilization: first results. Hum Reprod 10:2835–2839
Aboulghar MA, Mansour RT, Serour GI, Sattar MA, Amin YM (1996) Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen. J Assist Reprod Genet 13:38–42
Khamsi F, Yavas Y, Roberge S, Wong JC, Lacanna IC, Endman M (2001) Intracytoplasmic sperm injection increased fertilization and good-quality embryo formation in patients with non-male factor indications for in vitro fertilization: a prospective randomized study. Fertil Steril 75:342–347
Staessen C, Camus M, Clasen K, De Vos A, Van Steirteghem A (1999) Conventional in-vitro fertilization versus intracytoplasmic sperm injection in sibling oocytes from couples with tubal infertility and normozoospermic semen. Hum Reprod 14:2474–2479
Kim HH, Bundorf MK, Behr B, McCallum SW (2007) Use and outcomes of intracytoplasmic sperm injection for non-male factor infertility. Fertil Steril 88:622–628
Fang C, Tang J, Huang R, Li LL, Zhang MF, Liang XY (2012) Comparison of IVF outcomes using conventional insemination and ICSI in ovarian cycles in which only one or two oocytes are obtained. J Gynecol Obstet Biol Reprod. doi:10.1016/j.jgyn.2012.06.004
Xi Q, Zhu L, Hu J, Wu L, Zhang H (2012) Should few retrieved oocytes be as an indication for intracytoplasmic sperm injection? J Zhejiang Univ Sci B 13:717–722
Ikawa M, Inoue N, Benham AM, Okabe M (2010) Fertilization: a sperm’s journey to and interaction with the oocyte. J Clin Invest 120:984–994
Liu F, Qiu Y, Zou Y, Deng Z-H, Yang H, Liu DY (2011) Use of zona pellucida-bound sperm for intracytoplasmic sperm injection produces higher embryo quality and implantation than conventional intracytoplasmic sperm injection. Fertil Steril 95:815–818
Kunathikom S, Makemaharn O, Suksompong S, Laokirkkiat P (2001) Chromosomal analysis of “failed-fertilized” human oocytes resulting from in-vitro fertilization and intracytoplasmic sperm injection. J Med Assoc Thai 84:532–538
Miller JE, Smith TT (2001) The effect of intracytoplasmic sperm injection and semen parameters on blastocyst development in vitro. Hum Reprod 16:918–924
Chan AW, Luetjens CM, Dominko T, Ramalho-Santos J, Simerly CR, Hewitson L et al (2000) Foreign DNA transmission by ICSI: injection of spermatozoa bound with exogenous DNA results in embryonic GFP expression and live rhesus monkey births. Mol Hum Reprod 6:26–33
Ozil J-P, Banrezes B, Tóth S, Pan H, Schultz RM (2006) Ca2+ oscillatory pattern in fertilized mouse eggs affects gene expression and development to term. Dev Biol 300:534–544
Swann K, Lai FA (2013) PLCζ and the initiation of Ca(2+) oscillations in fertilizing mammalian eggs. Cell Calcium 53:55–62
Tesarik J, Sousa M (1994) Comparison of Ca2+ responses in human oocytes fertilized by subzonal insemination and by intracytoplasmic sperm injection. Fertil Steril 62:1197–1204
Ciapa B, Arnoult C (2011) Could modifications of signalling pathways activated after ICSI induce a potential risk of epigenetic defects? Int J Dev Biol 55:143–152
Fishel S, Timson J, Lisi F, Rinaldi L (1992) Evaluation of 225 patients undergoing subzonal insemination for the procurement of fertilization in vitro. Fertil Steril 57:840–849
Palermo G, Joris H, Derde MP, Camus M, Devroey P, Van Steirteghem A (1993) Sperm characteristics and outcome of human assisted fertilization by subzonal insemination and intracytoplasmic sperm injection. Fertil Steril 59:826–835
de Velde HV, Nagy ZP, Joris H, Vos AD, Steirteghem ACV (1997) Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection. Hum Reprod 12:2246–2250
Tatone C (2008) Oocyte senescence: a firm link to age-related female subfertility. Gynecol Endocrinol 24:59–63
Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R et al (2008) Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update 14:131–142
Carbone MC, Tatone C (2009) Alterations in the protein kinase C signaling activated by a parthenogenetic agent in oocytes from reproductively old mice. Mol Reprod Dev 76:122–131
Declaration of Interest
The authors report no declaration of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 International Society of Gynecological Endocrinology
About this chapter
Cite this chapter
Artini, P.G. et al. (2015). In Patients with Only One or Two Oocytes, Is IVF-ET or ICSI Better?. In: Fauser, B.C.J.M., Genazzani, A.R. (eds) Frontiers in Gynecological Endocrinology. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-09662-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-09662-9_12
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09661-2
Online ISBN: 978-3-319-09662-9
eBook Packages: MedicineMedicine (R0)